CervoMed Inc. Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31)
CervoMed Inc. (CRVO) reported Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) of $130.00 thousand for the 3-month period ending 2013-03-31, per its 10-Q/A filed 2013-05-20.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionCashFlowEffects · last filed 2013-05-20
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $130.00K.
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$91.00K.
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $51.00K.
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $170.00K.
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for fiscal 2012 was $130.00K.
- CervoMed Inc. share-based goods and nonemployee services transaction, cash flow effects (deprecated 2013-01-31) for fiscal 2010 was $1.36M.
| Period end | Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) 3 month | Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) 6 month | Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) 9 month | Share-based Goods and Nonemployee Services Transaction, Cash Flow Effects (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $130.00K 10-Q/A · filed 2013-05-20 | $39.00K derived: sum of 2 quarters · filed 2013-05-20 | $90.00K derived: sum of 3 quarters · filed 2013-05-20 | $260.00K derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-12-31 | -$91.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | -$40.00K derived: sum of 2 quarters · filed 2013-04-24 | $130.00K derived: sum of 3 quarters · filed 2013-04-24 | $130.00K 10-K/A · filed 2013-04-24 |
| 2012-09-30 | $51.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $221.00K derived: sum of 2 quarters · filed 2012-11-19 | $221.00K 10-Q · filed 2012-11-19 | |
| 2012-06-30 | $170.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2012-09-07 | $170.00K 10-Q/A · filed 2012-09-07 | ||
| 2012-03-31 | $0.00 10-Q/A · filed 2013-05-20 | |||
| 2010-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | $1.16M derived: sum of 2 quarters · filed 2012-05-21 | $1.36M 10-K · filed 2012-05-21 | |
| 2010-09-30 | $28.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $225.83K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $197.08K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |